Differential expression data for genes encoding key IRFs in HSV-2–treated MDDCs
Symbol . | Accession no. . | 3 Hours . | 6 Hours . | 12 Hours . |
---|---|---|---|---|
IRF-1 | NM_002198 | 9.5 | 41.5 | 34.1 |
IRF-2 | NM_002199 | 30.5 | 60.9 | 181.2 |
IRF-3 | NM_001571 | 3.4 | 25.2 | 20.2 |
IRF-4 | NM_002460 | 10.6 | 28.0 | 27.7 |
IRF-7 | NM_004031 | 2.5 | 6.4 | 0.1 |
IRF-8 | NM_002163 | 1.38 | 8.26 | 13.64 |
IRF-9 | NM_006084 | ND | ND | ND |
Symbol . | Accession no. . | 3 Hours . | 6 Hours . | 12 Hours . |
---|---|---|---|---|
IRF-1 | NM_002198 | 9.5 | 41.5 | 34.1 |
IRF-2 | NM_002199 | 30.5 | 60.9 | 181.2 |
IRF-3 | NM_001571 | 3.4 | 25.2 | 20.2 |
IRF-4 | NM_002460 | 10.6 | 28.0 | 27.7 |
IRF-7 | NM_004031 | 2.5 | 6.4 | 0.1 |
IRF-8 | NM_002163 | 1.38 | 8.26 | 13.64 |
IRF-9 | NM_006084 | ND | ND | ND |
Day 6 MDDCs were mock-treated or treated with HSV-2186 (MOI, 3), and IRF gene expression was determined by qPCR. Data are mean fold change in the expression of IRF genes in HSV-2– versus mock-treated cells for 3, 6, and 12 hours after treatment from 4 independent experiments.
ND indicates not determined.